I am an investor at General Catalyst, where I contribute to the health assurance team by driving success for the firm’s portfolio companies and new investments across biotech and life sciences.

Before joining GC, I was an investor at CaaS Capital Management, where I helped establish the firm’s biotech strategy for private and public markets. Prior to CaaS, I began my career as a consultant at Clarion, a biopharma consultancy firm.

I earned a BS in biology at Bard College, a healthcare certificate at Sloan School of Management, and my PhD in biology at MIT.